These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 8641481

  • 21. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
    Brache V, Alvarez-Sanchez F, Faundes A, Tejada AS, Cochon L.
    Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
    [Abstract] [Full Text] [Related]

  • 22. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI, Suvisaari J, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [Abstract] [Full Text] [Related]

  • 23. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
    Barbosa I, Coutinho E, Hirsch C, Ladipo O, Olsson SE, Ulmsten U.
    Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
    [Abstract] [Full Text] [Related]

  • 24. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
    Mäkäräinen L, van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H.
    Fertil Steril; 1998 Apr; 69(4):714-21. PubMed ID: 9548163
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
    Alvarez-Sanchez F, Brache V, Jackanicz T, Faundes A.
    Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
    [Abstract] [Full Text] [Related]

  • 26. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills.
    Alvarez F, Faundes A, Johansson E, Coutinho E.
    Fertil Steril; 1983 Jul; 40(1):120-3. PubMed ID: 6407876
    [Abstract] [Full Text] [Related]

  • 27. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [Abstract] [Full Text] [Related]

  • 28. Feasibility study of Nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception.
    Croxatto HB, Brache V, Massai R, Alvarez F, Forcelledo ML, Pavez M, Cochon L, Salvatierra AM, Faundes A.
    Contraception; 2006 Jan; 73(1):46-52. PubMed ID: 16371294
    [Abstract] [Full Text] [Related]

  • 29. Levonorgestrel implant use among adolescents.
    Mashburn M.
    J Pediatr Health Care; 1994 Jan; 8(6):255-60. PubMed ID: 7799199
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F, Brache V, Thevenin F, Cochon L, Faundes A.
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Neuroendocrine mechanism of anovulation in users of contraceptive subdermal implant of nomegestrol acetate (Uniplant).
    Barnhart K, Devoto L, Pommer R, Sir-Pettermann T, Robinovic J, Coutinho E.
    Fertil Steril; 1997 Feb; 67(2):250-5. PubMed ID: 9022598
    [Abstract] [Full Text] [Related]

  • 34. Subdermal contraceptive implants.
    Peralta O, Diaz S, Croxatto H.
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [Abstract] [Full Text] [Related]

  • 35. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
    Au CL, Affandi B, Rogers PA.
    Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
    [Abstract] [Full Text] [Related]

  • 36. Assessing the acceptability of Norplant contraceptive in four patient populations.
    Dugoff L, Jones OW, Allen-Davis J, Hurst BS, Schlaff WD.
    Contraception; 1995 Jul; 52(1):45-9. PubMed ID: 8521714
    [Abstract] [Full Text] [Related]

  • 37. Contraception with progestogens and progesterone during lactation.
    Shaaban MM.
    J Steroid Biochem Mol Biol; 1991 Jul; 40(4-6):705-10. PubMed ID: 1835650
    [Abstract] [Full Text] [Related]

  • 38. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
    Koopersmith TB, Lobo RA.
    Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T, Heikinheimo O, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [Abstract] [Full Text] [Related]

  • 40. Estradiol plasma levels during long-term treatment with Norplant subdermal implants.
    Croxatto HB, Díaz S, Pavez M, Brandeis A.
    Contraception; 1988 Oct; 38(4):465-75. PubMed ID: 3145171
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.